ICD-10-CM Code C79.11

Secondary malignant neoplasm of bladder

Version 2020 Billable Code Neoplasm Malignant Secondary

Valid for Submission

C79.11 is a billable code used to specify a medical diagnosis of secondary malignant neoplasm of bladder. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C79.11 might also be used to specify conditions or terms like malignant neoplasm of anterior wall of urinary bladder, malignant neoplasm of lateral wall of urinary bladder, malignant neoplasm of posterior wall of urinary bladder, malignant tumor involving bladder by direct extension from endometrium, malignant tumor involving bladder by direct extension from fallopian tube, malignant tumor involving bladder by direct extension from ovary, etc

ICD-10:C79.11
Short Description:Secondary malignant neoplasm of bladder
Long Description:Secondary malignant neoplasm of bladder

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C79.11:

Type 2 Excludes

Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
  • lymph node metastases C77.0

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Malignant neoplasm of anterior wall of urinary bladder
  • Malignant neoplasm of lateral wall of urinary bladder
  • Malignant neoplasm of posterior wall of urinary bladder
  • Malignant tumor involving bladder by direct extension from endometrium
  • Malignant tumor involving bladder by direct extension from fallopian tube
  • Malignant tumor involving bladder by direct extension from ovary
  • Malignant tumor involving bladder by direct extension from prostate
  • Malignant tumor involving bladder by direct extension from uterine cervix
  • Malignant tumor involving bladder by direct extension from uterus
  • Malignant tumor involving bladder by direct extension from vagina
  • Malignant tumor involving bladder by separate metastasis from endometrium
  • Malignant tumor involving bladder by separate metastasis from fallopian tube
  • Malignant tumor involving bladder by separate metastasis from ovary
  • Malignant tumor involving bladder by separate metastasis from prostate
  • Malignant tumor involving bladder by separate metastasis from uterine cervix
  • Malignant tumor involving bladder by separate metastasis from uterus
  • Malignant tumor involving bladder by separate metastasis from vagina
  • Malignant tumor of bladder neck
  • Malignant tumor of trigone of urinary bladder
  • Malignant tumor of urachus
  • Malignant tumor of ureteric orifice
  • Malignant tumor of vault of bladder
  • Metastasis to bladder of unknown primary
  • Metastatic malignant neoplasm to apex of urinary bladder
  • Metastatic malignant neoplasm to dome of urinary bladder
  • Neoplasm of anterior wall of urinary bladder
  • Neoplasm of apex of urinary bladder
  • Neoplasm of dome of urinary bladder
  • Neoplasm of lateral wall of urinary bladder
  • Neoplasm of posterior wall of urinary bladder
  • Neoplasm of trigone of urinary bladder
  • Neoplasm of urachus
  • Neoplasm of ureteric orifice of urinary bladder
  • Neoplasm of urinary bladder neck
  • pT3
  • pT3b
  • pT4
  • pT4
  • pT4
  • pT4
  • pT4: Invasion of bladder AND/OR rectum
  • Secondary malignant neoplasm of anterior wall of urinary bladder
  • Secondary malignant neoplasm of bladder
  • Secondary malignant neoplasm of lateral wall of urinary bladder
  • Secondary malignant neoplasm of parietal peritoneum
  • Secondary malignant neoplasm of posterior wall of urinary bladder
  • Secondary malignant neoplasm of trigone of urinary bladder
  • Secondary malignant neoplasm of urachus
  • Secondary malignant neoplasm of ureter
  • Secondary malignant neoplasm of ureteric orifice of urinary bladder
  • Secondary malignant neoplasm of urinary bladder neck
  • T4 : Endometrial tumor invades bladder mucosa and/or bowel mucosa
  • T4 : Tumor of uterine cervix/vagina invades mucosa of bladder or rectum and/or extends beyond true pelvis
  • Vagina TNM finding

Diagnostic Related Groups

The ICD-10 code C79.11 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 656 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC
  • 657 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC
  • 658 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC

Convert C79.11 to ICD-9

  • 198.1 - Sec malig neo urin NEC (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
      • Secondary malignant neoplasm of other and unspecified sites (C79)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C79.11 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

The Tabular must be reviewed for the complete diagnosis code.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»bladder (urinary)
C67.9C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »dome
C67.1C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »neck
C67.5C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »orifice
C67.9C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »orifice
    »ureteric
C67.6C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »orifice
    »urethral
C67.5C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »sphincter
C67.8C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »trigone
C67.0C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »urachus
C67.7C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »wall
C67.9C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »wall
    »anterior
C67.3C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »wall
    »lateral
C67.2C79.11D09.0D30.3D41.4D49.4
»bladder (urinary)
  »wall
    »posterior
C67.4C79.11D09.0D30.3D41.4D49.4
»urachus
C67.7C79.11D09.0D30.3D41.4D49.4
»ureter, ureteral
  »orifice (bladder)
C67.6C79.11D09.0D30.3D41.4D49.4
»ureter-bladder (junction)
C67.6C79.11D09.0D30.3D41.4D49.4
»urethra, urethral (gland)
  »orifice, internal
C67.5C79.11D09.0D30.3D41.4D49.4

Information for Patients


Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include

  • Blood in your urine
  • A frequent urge to urinate
  • Pain when you urinate
  • Low back pain

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute


[Learn More]